{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:50Z","timestamp":1791389030516,"version":"4.3.3"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.psychres.2026.116992","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:47:52Z","timestamp":1770047272000},"page":"116992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland"],"prefix":"10.1016","volume":"358","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6878-4276","authenticated-orcid":false,"given":"T.","family":"Aboulafia-Brakha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Buchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mabilais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Amberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9261-770X","authenticated-orcid":false,"given":"F.","family":"Seragnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0791-7967","authenticated-orcid":false,"given":"J-F","family":"Briefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-9179","authenticated-orcid":false,"given":"G.","family":"Thorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8530-5596","authenticated-orcid":false,"given":"M.","family":"Sab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Szczesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Iuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zullino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1379-0243","authenticated-orcid":false,"given":"L.","family":"Penzenstadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psychres.2026.116992_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.psycom.2023.100117","article-title":"Hypomodulation of salivary oxytocin in patients with borderline personality disorder: a naturalistic and experimental pilot study","volume":"3","author":"Aboulafia-Brakha","year":"2023","journal-title":"Psychiatry Res. Commun."},{"key":"10.1016\/j.psychres.2026.116992_bib0017","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"11","key":"10.1016\/j.psychres.2026.116992_bib0021","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.116992_bib0018","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2026.116992_bib0023","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/02698811241278873","article-title":"Naturalistic psychedelic therapy: the role of relaxation and subjective drug effects in antidepressant response","volume":"38","author":"Calder","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.116992_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J. Contextual Behav. Sci."},{"issue":"5","key":"10.1016\/j.psychres.2026.116992_bib0031","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2026.116992_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111249","article-title":"Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review","volume":"136","author":"Erkizia-Santamaria","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.116992_bib0022","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/02791072.2022.2059796","article-title":"Validation of a French version of the mystical experience questionnaire with retrospective reports of the most significant psychedelic experience among French users","volume":"55","author":"Fauvel","year":"2023","journal-title":"J. Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.psychres.2026.116992_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.31486\/toj.23.0076","article-title":"Efficacy and safety of psychedelics in treating anxiety disorders","volume":"23","author":"Feulner","year":"2023","journal-title":"Ochsner J."},{"issue":"5","key":"10.1016\/j.psychres.2026.116992_bib0001","first-page":"464","article-title":"A brief historical overview of psychedelic research","volume":"9","author":"Geyer","year":"2024","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"18","key":"10.1016\/j.psychres.2026.116992_bib0011","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.psychres.2026.116992_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/psymed.2022.0003","article-title":"Past, present, and future of psychedelics: a psychedelic medicine roundtable discussion","volume":"1","author":"Hendricks","year":"2023","journal-title":"Psychedelic Med. (New Rochelle)"},{"issue":"3","key":"10.1016\/j.psychres.2026.116992_bib0007","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.psychres.2026.116992_bib0030","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.psychres.2026.116992_bib0024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2026.116992_bib0006","article-title":"Serotonergic psychedelics - a comparative review comparing the efficacy, safety, pharmacokinetics and binding profile of serotonergic psychedelics","author":"Holze","year":"2024","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"1","key":"10.1016\/j.psychres.2026.116992_bib0029","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bcp.15887","article-title":"Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants","volume":"90","author":"Holze","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2026.116992_bib0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1027\/1015-5759.22.2.126","article-title":"Cognitive emotion regulation questionnaire (CERQ): confirmatory factor analysis and psychometric properties of the French translation","volume":"22","author":"Jermann","year":"2006","journal-title":"Eur. J. Psychol. Assess."},{"key":"10.1016\/j.psychres.2026.116992_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1265910","article-title":"How psychedelic-assisted therapy works for depression: expert views and practical implications from an exploratory Delphi study","volume":"14","author":"Johansen","year":"2023","journal-title":"Front. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2026.116992_bib0003","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/npp.2017.86","article-title":"Modern clinical research on LSD","volume":"42","author":"Liechti","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2026.116992_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2021.107467","article-title":"Improving cognitive functioning in major depressive disorder with psychedelics: a dimensional approach","volume":"183","author":"Magaraggia","year":"2021","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.psychres.2026.116992_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.110951","article-title":"Therapeutic potential of psychedelics: history, advancements, and unexplored frontiers","volume":"131","author":"Maia","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2026.116992_bib0013","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/acps.13778","article-title":"Randomized controlled trials of psilocybin-assisted therapy in the treatment of major depressive disorder: systematic review and meta-analysis","volume":"151","author":"Menon","year":"2025","journal-title":"Acta Psychiatr. Scand."},{"issue":"9","key":"10.1016\/j.psychres.2026.116992_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100725","article-title":"Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: a randomized trial","volume":"6","author":"Muller","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.psychres.2026.116992_bib0014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.euroneuro.2023.07.011","article-title":"Psilocybin-assisted therapy for depression: a systematic review and dose-response meta-analysis of human studies","volume":"76","author":"Perez","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2026.116992_bib0016","first-page":"806","article-title":"Psychoth\u00e9rapie assist\u00e9e par psych\u00e9d\u00e9liques (PAP): le mod\u00e8le genevoisPsychedelic assisted psychotherapy (PAP): the Geneva model","volume":"182","author":"Seragnoli","year":"2024","journal-title":"Ann. M\u00e9d.-Psychol. Rev. Psychiatr."},{"issue":"1","key":"10.1016\/j.psychres.2026.116992_bib0028","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1038\/s41598-024-58318-x","article-title":"Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial","volume":"14","author":"Sloshower","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2026.116992_bib0012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.euroneuro.2022.09.004","article-title":"A century of research on psychedelics: a scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs","volume":"64","author":"Solmi","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2026.116992_bib0019","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/01460869509087271","article-title":"Measuring the experience, expression, and control of anger","volume":"18","author":"Spielberger","year":"1995","journal-title":"Issues Compr. Pediatr. Nurs."},{"key":"10.1016\/j.psychres.2026.116992_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116337","article-title":"Efficacy and safety of psilocybin in the treatment of major depressive disorder (MDD): a dose-response network meta-analysis of randomized placebo-controlled clinical trials","volume":"344","author":"Swieczkowski","year":"2025","journal-title":"Psychiatry Res."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:35:58Z","timestamp":1782117358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S0165178126000533"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.116992","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.116992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116992"}}